JP2015506355A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506355A5
JP2015506355A5 JP2014549480A JP2014549480A JP2015506355A5 JP 2015506355 A5 JP2015506355 A5 JP 2015506355A5 JP 2014549480 A JP2014549480 A JP 2014549480A JP 2014549480 A JP2014549480 A JP 2014549480A JP 2015506355 A5 JP2015506355 A5 JP 2015506355A5
Authority
JP
Japan
Prior art keywords
alkyl
group
heterocyclyl
substituted
carbocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014549480A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015506355A (ja
JP6130399B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/077027 external-priority patent/WO2013098375A1/en
Publication of JP2015506355A publication Critical patent/JP2015506355A/ja
Publication of JP2015506355A5 publication Critical patent/JP2015506355A5/ja
Application granted granted Critical
Publication of JP6130399B2 publication Critical patent/JP6130399B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014549480A 2011-12-30 2012-12-28 新規アゼチジン誘導体、医薬組成物およびそれらの使用 Expired - Fee Related JP6130399B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11196170.2 2011-12-30
EP11196170 2011-12-30
PCT/EP2012/077027 WO2013098375A1 (en) 2011-12-30 2012-12-28 New azetidine derivatives, pharmaceutical compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2015506355A JP2015506355A (ja) 2015-03-02
JP2015506355A5 true JP2015506355A5 (https=) 2016-02-25
JP6130399B2 JP6130399B2 (ja) 2017-05-17

Family

ID=47553036

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014549480A Expired - Fee Related JP6130399B2 (ja) 2011-12-30 2012-12-28 新規アゼチジン誘導体、医薬組成物およびそれらの使用

Country Status (13)

Country Link
US (1) US8623860B2 (https=)
EP (1) EP2797884B1 (https=)
JP (1) JP6130399B2 (https=)
KR (1) KR20140115307A (https=)
CN (1) CN104093705A (https=)
AU (1) AU2012360797A1 (https=)
BR (1) BR112014015845A8 (https=)
CA (1) CA2861013A1 (https=)
EA (1) EA201400771A1 (https=)
IL (1) IL232914A0 (https=)
MX (1) MX2014007897A (https=)
PH (1) PH12014501514A1 (https=)
WO (1) WO2013098375A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2834164A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused benzoxazinones as ion channel modulators
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (https=) 2011-07-01 2018-04-28
WO2014061693A1 (ja) * 2012-10-17 2014-04-24 塩野義製薬株式会社 新規非芳香族炭素環又は非芳香族複素環誘導体
CN103483273B (zh) * 2013-09-12 2015-11-25 浙江工业大学 6-甲基-5-氟-2,4-嘧啶二胺类化合物及其制备与应用
HK1217448A1 (zh) 2013-09-12 2017-01-13 辉瑞大药厂 乙酰辅酶a羧化酶抑制剂用於治疗寻常痤疮的用途
EP3670496A3 (en) 2013-10-17 2020-09-30 Shionogi&Co., Ltd. Acc2 inhibitors
WO2015138909A1 (en) 2014-03-13 2015-09-17 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing cftr activity
US9745292B2 (en) 2014-03-13 2017-08-29 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
EP3157917B1 (en) 2014-06-19 2020-03-18 Proteostasis Therapeutics, Inc. Compounds, compositions and methods of increasing cftr activity
MA41253A (fr) 2014-12-23 2017-10-31 Proteostasis Therapeutics Inc Composés, compositions et procédés pour augmenter l'activité du cftr
US10738011B2 (en) 2014-12-23 2020-08-11 Proteostasis Therapeutics, Inc. Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
US10392378B2 (en) 2014-12-23 2019-08-27 Proteostasis Therapeutics, Inc. Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
US10344023B2 (en) 2014-12-23 2019-07-09 Proteostasis Therapeutics, Inc. Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
US10548878B2 (en) 2015-07-24 2020-02-04 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods of increasing CFTR activity
BR112018007021B1 (pt) 2015-10-06 2024-01-09 Proteostasis Therapeutics, Inc Composto, composição compreendendo os ditos compostos e uso dos mesmos para tratar fibrose cística
MA43775A (fr) 2016-04-07 2021-05-05 Proteostasis Therapeutics Inc Analogues du ivacaftor conentant des atomes de silicium
MA45397A (fr) 2016-06-21 2019-04-24 Proteostasis Therapeutics Inc Composés, compositions et procédés pour augmenter l'activité du cftr
CN110776504B (zh) * 2019-11-29 2021-07-30 扬州工业职业技术学院 一种苯异噁唑乙氧基环丁胺衍生物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ534582A (en) 2002-02-27 2006-03-31 Pfizer Prod Inc ACC inhibitors
DE102005055726A1 (de) 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
JP2009521448A (ja) 2005-12-21 2009-06-04 シェーリング コーポレイション ヒスタミンh3アンタゴニストとして有用なフェノキシピペリジンおよびそのアナログ
EP2032566A4 (en) 2006-06-12 2009-07-08 Merck Frosst Canada Ltd AZETIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE
AU2009304508A1 (en) 2008-10-17 2010-04-22 Merck Frosst Canada Ltd. Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
US20100280067A1 (en) 2009-04-30 2010-11-04 Pakala Kumara Savithru Sarma Inhibitors of acetyl-coa carboxylase
AR080969A1 (es) 2010-04-27 2012-05-23 Takeda Pharmaceutical Compuesto biciclico
MA34300B1 (fr) * 2010-05-13 2013-06-01 Amgen Inc Composés azotés hétérocycliques convenant comme inhibiteurs de la pde10

Similar Documents

Publication Publication Date Title
JP2015506355A5 (https=)
CN105745206B (zh) 用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂
JP6648137B2 (ja) ヘテロ環式誘導体およびその使用
JP4722851B2 (ja) キノリンカリウムチャネル阻害剤
RU2013149174A (ru) Новое имидазооксазиновое соединение или его соль
JP2015500856A5 (https=)
AU2012361581B2 (en) Effect potentiator for antitumor agents
RU2012104700A (ru) Азабициклосоединение и его соль
RU2012129168A (ru) Производные оксазина
RU2010126105A (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства
JP2015503540A5 (https=)
RS54339B1 (sr) Novi antimalarijski agensi
IL211291A (en) Picolinamide Compounds, Pharmaceuticals Containing Them, and Their Use in the Preparation of Cancer Drugs
He et al. Synthesis and biological evaluation of novel pyrazoline derivatives as potent anti-inflammatory agents
JP2007506743A (ja) イソキノリン系カリウムチャンネル阻害薬
JP2013509392A5 (https=)
RU2002131885A (ru) Антраниламиды и их применение в качестве лекарственных средств
RU2012108423A (ru) Ацилгуанидиновые производные с азотсодержащим циклом
JP2014516070A5 (https=)
AU2009335221A1 (en) Toluidine sulfonamides and their use
JP7203846B2 (ja) 置換アゼチジンジヒドロチエノピリジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用
JP2013540714A5 (https=)
JP2015500267A5 (https=)
CN105367582B (zh) 银杏内酯b衍生物及其在药物中的应用
EP4180429A1 (en) Pyrimidinone derivative, and preparation method therefor and use thereof against mycobacterium tuberculosis infection